The increased levels of TRAF1 in sunitinib-resistant RCC cells resulted from its increased TRAF1 mRNA stability which was mediated by elevated m6A modification of specific adenosines in TRAF1. The gene discussed is TRAF1; the disease is renal cell carcinoma.